Your browser doesn't support javascript.
loading
One-Year Outcomes After Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention: The T-TIME Randomized Trial.
Maznyczka, Annette M; McCartney, Peter J; Eteiba, Hany; Greenwood, John P; Muir, Douglas F; Chowdhary, Saqib; Gershlick, Anthony H; Appleby, Clare; Cotton, James M; Wragg, Andrew; Curzen, Nick; Oldroyd, Keith G; Lindsay, Mitchell; McEntegart, Margaret; Rocchiccioli, J Paul; Shaukat, Aadil; Good, Richard; Watkins, Stuart; Robertson, Keith; Malkin, Christopher; Martin, Lynn; Gillespie, Lynsey; Weir, Robin A; Ford, Thomas J; Petrie, Mark C; Murphy, Aengus; Petrie, Colin J; Ramparsad, Nitish; Wetherall, Kirsty; Fox, Keith A; Ford, Ian; McConnachie, Alex; Berry, Colin.
Affiliation
  • Maznyczka AM; British Heart Foundation Glasgow Cardiovascular Research Centre (A.M.M., P.J.M., K.G.O., T.J.F., M.C.P., C.B.), University of Glasgow, United Kingdom.
  • McCartney PJ; West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Glasgow, United Kingdom (A.M.M., P.J.M., H.E., K.G.O., M.L., M.M., J.P.R., A.S., R.G., S.W., K.R., L.M., M.C.P., C.B.).
  • Eteiba H; British Heart Foundation Glasgow Cardiovascular Research Centre (A.M.M., P.J.M., K.G.O., T.J.F., M.C.P., C.B.), University of Glasgow, United Kingdom.
  • Greenwood JP; West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Glasgow, United Kingdom (A.M.M., P.J.M., H.E., K.G.O., M.L., M.M., J.P.R., A.S., R.G., S.W., K.R., L.M., M.C.P., C.B.).
  • Muir DF; West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Glasgow, United Kingdom (A.M.M., P.J.M., H.E., K.G.O., M.L., M.M., J.P.R., A.S., R.G., S.W., K.R., L.M., M.C.P., C.B.).
  • Chowdhary S; Leeds University and Leeds Teaching Hospitals NHS Trust, United Kingdom (J.P.G.).
  • Gershlick AH; James Cook University Hospital NHS Trust, Middlesbrough, United Kingdom (D.F.M., C.M.).
  • Appleby C; Manchester University NHS Foundation Trust, United Kingdom (S.C.).
  • Cotton JM; Leicester University Hospitals NHS Trust, United Kingdom (A.H.G.).
  • Wragg A; Liverpool Heart and Chest Hospital NHS Foundation Trust, United Kingdom (C.A.).
  • Curzen N; Wolverhampton University Hospital NHS Trust, United Kingdom (J.M.C.).
  • Oldroyd KG; Barts and The London Hospital, London, United Kingdom (A.W.).
  • Lindsay M; University Hospital Southampton Foundation Trust and School of Medicine, University of Southampton, United Kingdom (N.C.).
  • McEntegart M; British Heart Foundation Glasgow Cardiovascular Research Centre (A.M.M., P.J.M., K.G.O., T.J.F., M.C.P., C.B.), University of Glasgow, United Kingdom.
  • Rocchiccioli JP; West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Glasgow, United Kingdom (A.M.M., P.J.M., H.E., K.G.O., M.L., M.M., J.P.R., A.S., R.G., S.W., K.R., L.M., M.C.P., C.B.).
  • Shaukat A; West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Glasgow, United Kingdom (A.M.M., P.J.M., H.E., K.G.O., M.L., M.M., J.P.R., A.S., R.G., S.W., K.R., L.M., M.C.P., C.B.).
  • Good R; West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Glasgow, United Kingdom (A.M.M., P.J.M., H.E., K.G.O., M.L., M.M., J.P.R., A.S., R.G., S.W., K.R., L.M., M.C.P., C.B.).
  • Watkins S; West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Glasgow, United Kingdom (A.M.M., P.J.M., H.E., K.G.O., M.L., M.M., J.P.R., A.S., R.G., S.W., K.R., L.M., M.C.P., C.B.).
  • Robertson K; West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Glasgow, United Kingdom (A.M.M., P.J.M., H.E., K.G.O., M.L., M.M., J.P.R., A.S., R.G., S.W., K.R., L.M., M.C.P., C.B.).
  • Malkin C; West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Glasgow, United Kingdom (A.M.M., P.J.M., H.E., K.G.O., M.L., M.M., J.P.R., A.S., R.G., S.W., K.R., L.M., M.C.P., C.B.).
  • Martin L; West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Glasgow, United Kingdom (A.M.M., P.J.M., H.E., K.G.O., M.L., M.M., J.P.R., A.S., R.G., S.W., K.R., L.M., M.C.P., C.B.).
  • Gillespie L; West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Glasgow, United Kingdom (A.M.M., P.J.M., H.E., K.G.O., M.L., M.M., J.P.R., A.S., R.G., S.W., K.R., L.M., M.C.P., C.B.).
  • Weir RA; James Cook University Hospital NHS Trust, Middlesbrough, United Kingdom (D.F.M., C.M.).
  • Ford TJ; West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Glasgow, United Kingdom (A.M.M., P.J.M., H.E., K.G.O., M.L., M.M., J.P.R., A.S., R.G., S.W., K.R., L.M., M.C.P., C.B.).
  • Petrie MC; Greater Glasgow and Clyde Health Board, United Kingdom (L.G.).
  • Murphy A; University Hospital Hairmyres, East Kilbride, United Kingdom (R.A.W.).
  • Petrie CJ; British Heart Foundation Glasgow Cardiovascular Research Centre (A.M.M., P.J.M., K.G.O., T.J.F., M.C.P., C.B.), University of Glasgow, United Kingdom.
  • Ramparsad N; British Heart Foundation Glasgow Cardiovascular Research Centre (A.M.M., P.J.M., K.G.O., T.J.F., M.C.P., C.B.), University of Glasgow, United Kingdom.
  • Wetherall K; West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Glasgow, United Kingdom (A.M.M., P.J.M., H.E., K.G.O., M.L., M.M., J.P.R., A.S., R.G., S.W., K.R., L.M., M.C.P., C.B.).
  • Fox KA; University Hospital Monklands, NHS Lanarkshire, United Kingdom (A.M., C.J.P.).
  • Ford I; University Hospital Monklands, NHS Lanarkshire, United Kingdom (A.M., C.J.P.).
  • McConnachie A; Robertson Centre for Biostatistics, Institute of Health and Wellbeing (N.R., K.W., I.F., A.M.), University of Glasgow, United Kingdom.
  • Berry C; Robertson Centre for Biostatistics, Institute of Health and Wellbeing (N.R., K.W., I.F., A.M.), University of Glasgow, United Kingdom.
Circ Cardiovasc Interv ; 13(2): e008855, 2020 02.
Article in En | MEDLINE | ID: mdl-32069113
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Thrombolytic Therapy / Tissue Plasminogen Activator / Fibrinolytic Agents / Percutaneous Coronary Intervention / ST Elevation Myocardial Infarction Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Circ Cardiovasc Interv Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2020 Document type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Thrombolytic Therapy / Tissue Plasminogen Activator / Fibrinolytic Agents / Percutaneous Coronary Intervention / ST Elevation Myocardial Infarction Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Circ Cardiovasc Interv Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2020 Document type: Article Affiliation country: United kingdom